Kristin Bedard, PhD

VP Discovery
Sutro Biopharma

Poster(s):

• Th42 - Next-generation Immunostimulatory Antibody-drug Conjugate (iADC) Combines Direct Tumor Killing and Innate Immune Stimulation to Provide Protective Anti-Tumor Immunity
  Thursday, June 23, 2022

  6:15 PM – 7:30 PM PT